Humana Inc. (HUM) has partnered with DrFirst to launch a program designed to close care gaps for patients with chronic conditions, particularly targeting statin therapy usage for eligible patients. The initiative aims to improve health outcomes and reduce costs associated with cardiovascular risks linked to statin therapy.
Utilizing DrFirst’s prescription orchestration platform, Humana will send statin recommendations directly to healthcare providers, allowing for streamlined approvals and prescriptions. As of June 30, 2025, Humana reported a total medical membership of 14.8 million, with premiums having increased by 8.6% year-over-year in the first half of 2025.
DrFirst’s platform is set to enhance collaboration among over 350,000 prescribers and 71,000 pharmacies, improving the sharing of critical patient information and supporting better health outcomes.
